Stem Cell Suspension Culture Neural Tissue Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing cell masses containing neural cells or neural tissue and nonneural epithelial tissue from pluripotent stem cells are costly due to the use of expensive recombinant proteins and require xenogeneic components, and there is a need for a method that allows for efficient scaling up and easy separation of nonneural epithelial tissue.
Innovation Solution
A method involving suspension culturing of pluripotent stem cells in the presence of a Wnt signal transduction pathway inhibiting substance and a BMP signal transduction pathway activating substance, with optimization of BMP4 concentration and timing, and the use of TGFβ family and Sonic hedgehog signal transduction pathway modulators to reduce costs and enhance differentiation efficiency, all while avoiding feeder cells and xenogeneic components.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If a Wnt signal transduction pathway inhibiting substance and BMP signal transduction pathway activating substance are used in suspension culturing, then a cell mass containing neural cells/tissue and non-neural epithelial tissue can be produced, but the cost increases due to expensive recombinant proteins
Solution Approach 1:
The patent optimizes the concentration and timing of BMP4 addition during suspension culturing. By adding BMP4 at specific time points (e.g., 48-72 hours after starting culturing) and at optimized concentrations, the method achieves efficient differentiation into neural and epithelial tissues while reducing the total amount of expensive recombinant protein required compared to continuous high-concentration treatment
Solution Approach 2:
The method performs preliminary suspension culturing with Wnt inhibition before BMP4 addition to pre-condition the pluripotent stem cells. This preliminary action establishes the appropriate cellular state that responds more efficiently to subsequent BMP4 treatment, reducing the overall protein quantity needed for achieving the desired cell mass composition
2Reliability
If mouse sarcoma-derived basement membrane preparation (Matrigel) is used in suspension culturing, then cell aggregate formation is improved, but xenogeneic contamination occurs
Solution Approach 1:
The patent removes the mouse sarcoma-derived basement membrane preparation (Matrigel) from the culturing system and replaces it with a feeder-free suspension culturing method. This extraction eliminates the source of xenogeneic contamination while maintaining cell aggregate formation through optimized suspension culturing conditions including appropriate media composition and signal transduction pathway modulation
Solution Approach 2:
The method uses a chemically defined, xeno-free suspension culturing system that does not rely on animal-derived basement membrane preparations. This approach replaces the problematic Matrigel with a disposable, defined media system that eliminates xenogeneic risks while maintaining the necessary cellular functions
3Shape
If adhesion culturing on a flat plane is used, then three-dimensional tissue structures can be formed, but scaling up becomes difficult and requires specific container treatments
Solution Approach 1:
The patent transitions from two-dimensional adhesion culturing on flat surfaces to three-dimensional suspension culturing. By suspending cell aggregates in culture medium and modulating signal transduction pathways (Wnt inhibition and BMP activation), the method achieves three-dimensional tissue structure formation without requiring coated containers or flat surfaces, enabling straightforward scaling to larger volumes
4Manufacturing precision
If high concentration BMP4 is added for a long time, then differentiation into neural and epithelial tissues is achieved, but production cost increases due to expensive recombinant protein
Solution Approach 1:
The patent employs periodic or staged addition of BMP4 during suspension culturing rather than continuous high-concentration treatment. By adding BMP4 at specific time intervals and optimizing the duration of treatment, the method achieves effective tissue differentiation while minimizing the total quantity of expensive recombinant protein consumed
Solution Approach 2:
The method uses optimized, partial action of BMP4 at specific concentrations and time points rather than excessive continuous treatment. This approach achieves the necessary differentiation threshold while avoiding unnecessary protein consumption, thereby reducing production costs while maintaining manufacturing precision
Data Source
AI summary
The present invention aims to provide a method for efficiently producing, from pluripotent stem cells, a cell mass containing a neural cell or neural tissue, and nonneural epithelial tissue. A method for producing a cell mass containing 1) neural cells or neural tissue and 2) nonneural epithelial tissue, including the following steps (1) and (2):(1) a first step of suspension-culturing pluripotent stem cells to form a cell aggregate in the presence of a Wnt signal transduction pathway inhibiting substance,(2) a second step of suspension-culturing the aggregate obtained in the first step in the presence of a BMP signal transduction pathway activating substance, thereby obtaining a cell mass comprising 1) neural cells or neural tissue and 2) nonneural epithelial tissue.